These results indicated that both IFITM3 deficiency and STAT1 deficiency disrupt the IFITM3-STAT1 feedback loop in TI-Tregs and could enhance the anti-tumor immune response by suppressing the immunosuppressive functions of TI-Tregs. The gene discussed is IFITM3; the disease is neoplasm.